The move is being led by a legal firm that successfully sued the company for £4.1billion ($4.7bn) in the US on behalf of 22 women who developed ovarian cancer.The move is being led by a legal firm that successfully sued the company for £4.1billion ($4.7bn) in the US on behalf of 22 women who developed ovarian cancer.Read MoreHealth News | Mail Online